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The current dogma is that obesity-associated hepatic
inflammation is due to increased Kupffer cell (KC)
activation. However, recruited hepatic macrophages
(RHMs) were recently shown to represent a sizable
liver macrophage population in the context of obesity.
Therefore, we assessed whether KCs and RHMs, or
both, represent the major liver inflammatory cell type
in obesity. We used a combination of in vivo macro-
phage tracking methodologies and adoptive transfer
techniques in which KCs and RHMs are differentially
labeled with fluorescent markers. With these
approaches, the inflammatory phenotype of these
distinct macrophage populations was determined
under lean and obese conditions. In vivo macrophage
tracking revealed an approximately sixfold higher
number of RHMs in obese mice than in lean mice,
whereas the number of KCs was comparable. In
addition, RHMs comprised smaller size and immature,
monocyte-derived cells compared with KCs. Further-
more, RHMs from obese mice were more inflamed and
expressed higher levels of tumor necrosis factor-a and
interleukin-6 than RHMs from lean mice. A comparison
of the MCP-1/C-C chemokine receptor type 2 (CCR2)
chemokine system between the two cell types showed
that the ligand (MCP-1) is more highly expressed in KCs
than in RHMs, whereas CCR2 expression is approxi-
mately fivefold greater in RHMs. We conclude that KCs
can participate in obesity-induced inflammation by
causing the recruitment of RHMs, which are distinct
from KCs and are not precursors to KCs. These
RHMs then enhance the severity of obesity-induced in-
flammation and hepatic insulin resistance.
Insulin resistance is a major pathophysiologic defect
underlying the etiology of type 2 diabetes (1). In recent
years, chronic tissue inflammation has been identified as
a major contributor to the decreased insulin sensitivity in
obesity. This proinflammatory state is characterized by
a number of changes in immune cell populations in adi-
pose tissue, including increased proinflammatory macro-
phages (2,3). In addition, increased circulating levels of
cytokines have been reported across several experimental
rodent models as a well as in obese humans (4–7).
The liver is responsible for the metabolism, synthe-
sis, storage, and distribution of nutrients and is a key
organ with central importance in the maintenance of
glucose homeostasis. Insulin stimulates storage of
glucose as liver glycogen and inhibits hepatic glucose
production by restricting glycogenolysis and gluconeo-
genesis (8). In obesity and type 2 diabetes, the liver is
insulin resistant, resulting in increased gluconeogenesis
and glycogenolysis leading to increased overall hepatic
glucose production (9,10). Other cardinal features of
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obesity are nonalcoholic fatty liver disease and hepatic
inflammation (11,12). Thus, obesity promotes hepatic
inflammation in humans and rodents, leading to in-
creased production of proinflammatory cytokines and
acute-phase reactants. In addition, there is strong evi-
dence that macrophages play a significant role in hepatic
inflammation and insulin resistance. In support of these
ideas, chemical deletion or genetic impairment of he-
patic macrophages in obese mice leads to an improve-
ment in insulin sensitivity (13–15).
Understanding this phenomenon in the liver is partic-
ularly complex, due to the heterogeneity of hepatic
macrophage populations. Thus, in insulin resistance,
there is an increased number of infiltrating macrophages
in the liver (16,17). In addition, a large proportion of
hepatic macrophages consist of resident Kupffer cells
(KCs) (18). KCs are predominantly localized to the hepatic
sinusoids and exhibit phagocytic activity toward blood-
born materials entering the liver (18,19). Although KCs
account for ;15% of the total liver cell population (20),
attempts to functionally characterize these cells have had
limited success because isolating and characterizing these
cells as a discrete population distinct from infiltrating
macrophages have been difficult.
To elucidate the roles of recruited hepatic macrophages
(RHMs) vs. KCs in the development of obesity-associated
hepatic inflammation and insulin resistance, we have used
a combination of in vivo macrophage tracking and
adoptive transfer methodologies, in which KCs and
RHMs are differentially labeled with fluorescent markers
and analyzed by FACS. This allowed us to quantitate the
numbers of these cells, their genomic signatures, and
inflammatory phenotypes in both the lean and obese
state. Our results show that obesity is associated with
activation of KCs, which leads to migration of RHMs into
the liver augmenting the severity of obesity-induced
hepatic inflammation.
RESEARCH DESIGN AND METHODS
Animal Care and Use
Male C57Bl/6 mice were fed normal chow (NC; 13.5%
fat; LabDiet) or a high-fat diet (HFD; 60% fat; Research
Diets, Inc.) ad libitum for 15–20 weeks from 8 weeks of
age. Chemokine receptor type 2 (CCR2) knockout (KO)
and wild-type (WT) littermates were provided by
Taconic Inc. (Hudson, NY). Animals were housed in
a specific pathogen-free facility and given free access
to food and water. The University of California San
Diego Animal Care and Use Committee approved all
procedures.
Monocyte Preparation
Leukocyte pools from C57BL/6 male mice 12 weeks of age
underwent red blood cell lysis, and monocyte subsets were
enriched with the EasySep Mouse Monocyte Enrichment
Kit (STEMCELL Technologies, Vancouver, BC, Canada)
following the manufacturer’s instructions.
In Vitro Labeling
Isolated monocytes (5 3 106 to 10 3 106) were washed
once in serum-free medium (RPMI-1640) and suspended
in 2 mL Diluent Solution C (included in the PKH26 label-
ing kit). Two milliliters PKH26 (Sigma-Aldrich, St. Louis,
MO) at 2 3 1023 mol in Diluent C was added and mixed,
and the cells were incubated for 10 min at room temper-
ature in the dark. The staining reaction was halted by
addition of an equal volume (2 mL) of medium supple-
mented with 10% FBS. The mixture was centrifuged, and
the cells were washed once and resuspended in serum-
containing medium.
In Vivo Migration
Subsequent to labeling with PKH26 dye, monocytes were
counted, and ;5 3 105 viable cells were suspended in 0.2
mL PBS and injected via the retro-orbital venous sinus of
each group of mice. Five days after of injection, the non-
parenchymal cells (NPCs) were immediately isolated from
perfused liver and analyzed by FACS.
Fluorescence Microscopy of Mouse Liver
Immunofluorescence study of mouse liver was described
in a previous study (17).
KC Labeling Model
Lean NC- and HFD-fed C57Bl/6 mice were injected via the
retro-orbital venous sinus with fluorescein isothiocyanate
(FITC)-dyed beads (Fluoresbrite 0.5 mm; Polysciences,
Inc.) (21). Two days after the injection, the mice were
irradiated with a dose of 10 Gy and were reconstituted
6 hours later with 1.5 3 106 bone marrow cells isolated
from WT mice. Two weeks after reconstitution, blood cell
counts were normal.
Isolation of Bone Marrow Cells for Reconstitution
Bone marrow was flushed out of the fibula and femur and
washed three times with ice-cold PBS, then passed through
a 25-gauge syringe to avoid clots. Red blood cell lysis was
performed (eBioscience, San Diego, CA), and the cells were
then counted and resuspended at a concentration of 5 3
106 cells/mL.
FACS Analysis of Liver Macrophages
For liver macrophage analysis, NPCs were prepared by
two-step liver collagenase digestion and fractionation on
a two-step Percoll density gradient, as previously de-
scribed (22). The antibodies for surface staining were F4/
80 (BM8), Ly6C (AL-21), CD11b (M1/70), and CD11c
(N418; eBioscience). Numbers obtained were subsequently
represented as the percentage of the highest subsets. Un-
stained, single-stained, and fluorescence minus one con-
trols were used for setting compensation and gates.
RNA Isolation and Quantitative PCR
Total RNA isolation and quantitative PCR (q-PCR) were
performed as described previously (23). Gene expression
levels were calculated after normalization to the standard
housekeeping genes RPS3 and GAPDH using the DDCT
method (23) and expressed as relative mRNA levels
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compared with the internal control. Primer information is
available upon request.
Western Blot Analysis
The amount of tumor necrosis factor-a (TNF-a) in
PKH26+ cells from lean and obese mouse NPCs were de-
termined in total cellular extracts by immunoblot using
the commercial antibodies given in parentheses (TNF-a
and HSP90 a/b, Santa Cruz Biotechnology, Inc., Santa
Cruz, CA). The cells were homogenized in radioimmuno-
precipitation assay buffer supplemented with protease
and phosphatase inhibitors (Roche Diagnostics, Indianap-
olis, IN). The protein bands were analyzed using densi-
tometry and ImageJ image analysis software.
Hepatic Glucose Output Assay
Mice were infused through the inferior vena cava with a
calcium-free HEPES-phosphate buffer, followed by Liber-
ase TM collagenase solution (Roche Diagnostics) for
another 5 min. The digested livers were excised, and cells
were teased out in Earle balanced salt solution without
collagenase. Hepatocyte suspension was filtered and
centrifuged at 50g for 6 min, and the pellet was resus-
pended in Williams Medium E (Life Technologies, Inc.)
fortified with glutamax, antibiotics, 10% FBS, and dexa-
methasone (10 nmol/L) and allowed to attach for 6 h on
collagen-coated plates. After attachment, medium was
switched to Williams E without serum and dexametha-
sone (culture medium) and incubated overnight in a 5%
CO2 incubator. During this incubation, if condition me-
dium (CM) was used for an experiment, CM was diluted
1:1 with the culture medium and incubated overnight. In
control wells without CM, RPMI was used to dilute the
culture medium. The next morning, cultures were washed
in HEPES-phosphate–salt–bicarbonate buffer containing
0.2% BSA and incubated in the same buffer containing
insulin or glucagon and 14C-pyruvate (2 mmol/L, 0.5 mCi
pyruvate/incubation, PerkinElmer) as substrate. Cells
were preincubated (in absence of substrate) for 30 min
with insulin (10 nmol/L) or glucagon (10 ng/mL), or
a combination, followed by 3 h incubation with the sub-
strate. Tubes were vortexed and centrifuged, and the
supernatants were transferred to a fresh set of tubes
containing 200 mg mixed-bed ion-exchange resins,
AG-501 3 8 resins (BioRad). These tubes were vortexed
intermittently for 15 min and centrifuged, and the super-
natants containing radiolabeled glucose were transferred to
scintillation vials for counting radioactivity. Cells on the
plates were dissolved in 1N NaOH for protein estimation.
Library Preparation, Sequencing, and Data Analyses
RNA was quantified using a NanoDrop 1000 (Thermo-
Fisher, Waltham, MA) and assessed on a Tapestation
(Agilent, Santa Clara, CA). DNA libraries were prepared
according to the manufacturer’s instructions (Illumina,
San Diego, CA). Each library was sequenced on the
Illumina HISeq2000 platform using paired-end 100,
non–strand-specific sequencing strategy. Reads were first
mapped to the mouse transcriptome using the Bowtie 2
algorithm (24), counted as reads per gene, and then ana-
lyzed using the statistical algorithm DESEq (25). Signifi-
cance is calculated as the q value, which is the largest false
discovery rate at which a gene is deemed differentially
expressed (26,27). Genes were sorted by q value and
then underwent gene ontology and pathway analyses us-
ing a nonparametric variant of the Gene Set Enrichment
Analysis algorithm (28). Principal component analysis was
performed in R software.
Data Analysis
The values presented are expressed as the means 6 SEM.
The statistical significance of the differences among var-
ious treatments was determined by one-way ANOVA
with the Bonferroni correction using GraphPad Prism
6.0 software (San Diego, CA). P , 0.05 was considered
significant.
RESULTS
Isolation and Characterization of Nonparenchymal
Cells From Lean and Obese Mouse Livers
To define the characteristics of innate immune cells and
KCs in the liver, we isolated NPCs from lean and obese
mouse livers, followed by FACS and qPCR analyses (Fig.
1A). As shown in Fig. 1B, livers from lean mice contained
F4/80+/CD11b+ cells (R1), whereas livers from obese mice
exhibited two distinct populations, which are F4/80+/
CD11b+ (R2) or F4/80low/CD11b+ (R3). The number of
R3 cells was negligible in lean mice, with a striking expan-
sion of this cell population in obese mice (Fig. 1B).
According to forward and side-scatter analyses, cells in
the R3 population were smaller and less granular than
R2 cells (Fig. 1C). The gene expression levels of F4/80
and CD11b were consistent with the FACS results, show-
ing that F4/80 levels were greater in R2 compared with
R3 cells, whereas CD11b was approximately fourfold
lower in R2 than in R3 cells. Interestingly, expression of
Ly6C and CCR2 is markedly higher in R3 compared with
R2 and R1 cells, whereas MCP-1 expression is significantly
higher in R2 and R1 cells. This suggests that R3 cells
represent fresh RHMs derived from circulating mono-
cytes. By immunohistochemistry of liver sections, we
assessed the colocalization of TNF-a with the macrophage
marker F4/80. As seen in Fig. 1E, colocalization was low in
lean NC mice, whereas both markers were highly colocal-
ized in obese, HFD-fed mice. The same results were ob-
served for colocalization of CD11b and F4/80.
Tracking and FACS Analysis of PKH26-Labeled
Monocytes to Liver in Lean and Obese Mice
Figure 1B clearly shows two different macrophage popu-
lations in obese mouse liver. To further assess this, we
performed in vivo macrophage tracking studies, as pre-
viously described (17). With this method, circulating
monocytes from donor mice are labeled ex vivo with the
fluorescent marker PKH26 and then injected into recipi-
ent mice. The appearance of these labeled cells as RHMs
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was then analyzed over time by FACS and expression
analysis, as shown in Fig. 2A. After injection of PKH26+
cells, the NPCs were isolated at the indicated time and
gated first for PKH26 and then plotted for CD11b and
F4/80. The overall accumulation of PKH26+ cells was
much greater in obese versus lean mouse liver (Fig. 2B).
The RHMs in HFD mouse liver appeared as two discrete
populations; F4/80low/CD11b+ (blue-gated) and F4/80high/
CD11b+ (red-gated) fraction, similar to the R3 and R2
cells observed in Fig. 1B. This suggests that newly
recruited monocytes initially appear in the R3 fraction
and then convert into the R2 fraction as they mature
into differentiated macrophages. At day 1, ;15% of the
total NPCs are fluorescently labeled in obese mice, dem-
onstrating their origin from the injected labeled mono-
cytes and indicating they are newly recruited RHMs:
2.6 6 0.7% in lean and 19.6 6 2.9% in obese mice are
PKH26+ cells from the F4/80low/CD11b+ cells (R3 fraction).
Figure 1—Isolation and characterization of NPCs from lean and obese mouse liver. A: Schematic diagram of isolation of NPCs from NC-fed
lean vs. HFD-fed obese mouse liver. B: FACS analysis of NPCs from lean (NC) and obese (HFD) mouse liver with CD11b and F4/80 gating.
NC mouse liver R1 population is labeled in blue, HFD mouse liver R2 population is labeled in green, and R3 population is labeled in red. The
scattergram is representative of five to six independent mice from each group. C: Representative histogram plots depict the distribution of
values of side (indicating relative granularity, left panel) and forward (indicating relative size, right panel) light scatter obtained from FACS
analysis of R2 and R3 population from panel B. D: The relative gene expression from R1, R2, and R3 cell populations obtained from FACS
sorting is shown. Data represent mean 6 SEM (n = 5–6). *P < 0.05 compared with R2 vs. R3. E: TNF-a, F4/80, and CD11b protein
expression in lean and obese mouse liver analyzed by immunohistochemistry. The image is representative of six independent mice from
each group. Scale bar indicates 100 mm.
diabetes.diabetesjournals.org Morinaga and Associates 1123
By 5 days after injection, there was a sixfold increase in
PKH26+ cells in obese versus lean mouse livers (Fig. 2C).
Because CCR2 is highly expressed in the R3 cells (Fig.
1D), we used labeled monocytes derived from WT and
CCR2 KO donor mice and injected them into obese WT
recipients (Fig. 2D). There was an ;80% decrease in RHM
recruitment with the CCR2 KO monocytes (Fig. 2D), dem-
onstrating the importance of the MCP-1/CCR2 system for
targeting monocytes to the RHM fraction (17). In the
same cells, we also analyzed the amount of intracellular
inflammatory cytokines by flow cytometry. Intracellular
TNF-a and interleukin-6 protein levels were much higher
in PKH26+ cells from obese mice compared with lean mice
(Fig. 2E). In addition, we collected PKH26+ cells from the
total NPC fraction sorted by FACS and cultured these cells
overnight. As expected, TNF-a protein expression was
significantly greater in PKH26+ cells from obese mice
compared with lean mice (Fig. 2F).
A
B C
D
E
F
Figure 2—RHM isolation with PKH26 fluorescent labeling. A: Schematic diagram of RHM isolation and characterization with PKH26+
fluorescent-labeled monocytes. B: FACS analyses of PKH26+ cells isolated from lean or obese mouse livers 1, 5, or 16 days after injection
with PKH26+-labeled monocytes. Cells were first gated out of total NPCs for PKH26 and then plotted for F4/80+ and CD11b+ fluorescence.
F4/80low/CD11b+ (blue-gated) and F4/80high/CD11b+ (red-gated) fraction, similar to the R3 and R2 cells observed in Fig. 1B. The scatter-
gram is representative of four to five independent mice from each group. C: Average number of PKH26+ cells from lean and obese mouse
liver was analyzed by FACS and then plotted as fold induction6 SEM from three independent experiments (n = 4 in each group). *P < 0.05
compared with NC vs. HFD. D: FACS analysis of the average number of PKH26+ cells isolated from HFD-fed recipient mice after injection
PKH26+-labeled monocytes fromWT or CCR2 KO donor mice. Mean6 SEM from three independent experiments (n = 5 in each group). *P<
0.05 compared with WT vs. CCR2 KO. E: TNF-a+ (left) and interleukin-6+ (right) cells were gated out of PKH26+ cells from NPCs of lean and
obese mouse liver by FACS and then plotted as the mean 6 SEM from three independent experiments (n = 5 in each group). *P < 0.05
compared with NC vs. HFD. F: Western blot analysis of TNF-a protein expression in PKH26+ cells from lean and obese mouse NPCs.
PKH26+ cells from lean and obese mouse NPCs were sorted by FACS and then cultured overnight before protein isolation. HSP90 was
used as the loading control. The image is representative from three independent Western blots (n = 2 for each group per Western blot).
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Characterization of RHMs and KCs by Adoptive
Transfer and Fluorescent Labeling
On the basis of the finding that KCs are relatively
radioresistant (29), we developed a strategy to selectively
label these cells with green fluorescent (FITC) beads. Be-
fore the administration of lethal irradiation, NC and HFD
mice were injected with FITC beads to label all phagocy-
tizing cells (21). The injected mice were then irradiated
with 10 Gy and reconstituted with bone marrow from WT
mice. Two weeks after reconstitution, mice were injected
with PKH26+ monocytes. Because KCs are relatively radio-
resistant, with this approach, the green fluorescent cells
(FITC+ cells) that survive the irradiation are KCs, whereas
PKH26+ cells are RHMs (Fig. 3A). This model allowed us
to separate FITC+ KCs from PKH26+ RHMs by flow
cytometry. NPC fractions were prepared, and FACS anal-
ysis revealed discrete populations of PKH26+ RHMs and
FITC+ KCs (Fig. 3B). Figure 3B shows that PKH26+ RHMs
A
B C
D
E
Figure 3—Identification of KCs in mouse liver. A: Schematic diagram of the irradiation model used to distinguish KC and RHM. i.v.,
intravenous. B: FITC+ KCs and PKH26+ newly infiltrating macrophages from HFD mice were plotted in forward and side scatter. The
scattergram is representative of five independent mice. C: Whole-liver FITC+ KC numbers from mice fed NC were compared with mice after
12 weeks of HFD feeding. Data represent mean 6 SEM (n = 5–6). D: MCP-1 and CCR2 mRNA expression were measured from FACS-
sorted KCs and RHMs isolated from NC and HFD mice. Data represent mean 6 SEM (n = 5). *P < 0.05 compared with KC vs. RHM. E:
Hepatic glucose production assay in mouse hepatocytes. Hepatocytes were cultured with conditioned media from FACS-sorted KCs and
RHMs from NC (N) and HFD (H) mice. Data represent mean 6 SEM (n = 5). *P < 0.05 compared with glucagon and insulin in RPMI.
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were significantly smaller in size, whereas FITC+ KCs were
larger and more heterogeneous in size, consistent with Fig.
1C. PKH26 and FITC labeling showed there was no differ-
ence in KC numbers between lean and obese mice (Fig. 3C).
FACS-sorted RHMs and KCs were analyzed for gene
expression. Interestingly, CCR2, a chemokine receptor
directing monocyte homing to the liver, was highly
expressed in PKH26+ RHMs compared with KCs, whereas
the ligand, MCP-1, was highly expressed in KCs relative to
RHMs, consistent with Fig. 1D. These results suggest that
KCs are the main source of MCP-1, leading to increase
recruitment of RHMs through the CCR2 (Fig. 3D) (30,31).
To determine functional differences between KCs and
RHMs, we measured hepatic glucose output (HGO) from
primary hepatocytes treated with CM from overnight
cultured KCs and RHMs. For this experiment, we cultured
FACS-sorted KCs and RHMs from NC and HFD mice
overnight and collected the CM to treat cultured mouse
hepatocytes for 16 h. We found that glucagon stimulates
HGO and that this effect was completely inhibited by
insulin in RPMI (control medium), NC KC-CM, HFD KC-
CM, and NC RHM-CM. In contrast, RHM-CM from HFD
mice directly stimulated HGO (Fig. 3E). Most importantly,
HFD RHM-CM blocked the effect of insulin to inhibit
glucagon-stimulated HGO (Fig. 3E). Thus, components
in RHM-CM, but not KC-CM, from HFD mice can pro-
mote HGO and attenuate insulin’s normal inhibitory
effects on this aspect of hepatic metabolism.
Transcriptome Analysis of RHMs and KCs
RNA sequencing was used to determine the transcriptome
of FACS-sorted RHMs and KCs from mice fed NC or the
HFD (three biological replicates per group). Principal
component analysis of the expressed genes showed that
replicate samples clustered together (Fig. 4A). Bioin-
formatics analyses revealed marked differences in the
transcriptome of KCs and RHMs (Fig. 4B), with 3,019
differentially expressed genes (q, 0.05) between KCs and
RHMS isolated from mice fed NC and 1,239 differentially
expressed genes from mice fed the HFD. We then inves-
tigated the gene expression changes induced by the HFD
within each cell type. We determined that 1,230 genes
were differentially expressed between NC and the HFD
within KCs and that 1,307 genes were differentially
expressed in RHMs. Venn diagram analyses revealed that
these two cell types responded quite differently to the HFD
(Fig. 4C). Thus, the HFD induced different gene sets in
these two distinct cell types (KCs and RHMs), with only
287 (23.3%) differentially expressed genes in common.
We performed Gene Ontology (GO) analysis of differ-
entially expressed genes within these four comparisons
and identified enriched GO terms to gain insights into
the biological processes (BP) within these cells types
(Supplementary Table 1). We identified 656 BPs that
were significantly different between these cell types
(Bonferroni-adjusted P , 0.01). The immune system
was a recurrent theme in these enriched BP terms; in
particular, “inflammatory response,” (GO:0006954) was
significantly different (Bonferroni P = 2.58E-36) when
comparing the diet effects within cell types (Supplemen-
tary Table 1). This enriched BP term “inflammatory re-
sponse” contained 162 genes that were differentially
expressed (q , 0.05) and are displayed in a heat map
reflecting the fold change between groups (Fig. 4D). We
adjusted these gene counts to reflect the number of KCs
(31.17) and RHMs (35.7) present in the liver in HFD-
fed mice compared with NC-fed mice. To identify poten-
tial surface markers to distinguish KCs from RHMs, we
identified the differentially expressed cell surface genes
(extracellular region, GO:0044421). Table 1 reports the
most discriminating genes based on high expression and
fold changes between the two cell types on both diets.
DISCUSSION
These studies show that in the context of obesity, liver
macrophages are made up of heterogeneous, discrete
populations. The first is the resident hepatic macrophage,
the KC, which shows high levels of inflammatory markers
after being activated and appears to be a major source of
liver-derived MCP-1 after HFD. In addition, upon HFD
feeding, there is a marked increase in the accumulation
of fresh RHMs, and these cells are distinct from KCs. The
RHMs initially appear in the liver as monocytic cells,
expressing high levels of LY6c and CCR2 (R3 in Fig. 1)
(16,17); over time, these cells take on the characteristics
of differentiated macrophages, which we term RHMs.
Obesity not only increases the numbers of RHMs but
also enhances their proinflammatory potential, as seen
by increased expression of a variety of inflammatory path-
way genes (Fig. 4D). These cells express high levels of
CCR2 and low levels of MCP-1, whereas KCs express
high levels of MCP-1 and low levels of CCR2. This leads
to the view that in HFD mice, obesity-resident KCs se-
crete increased amounts of MCP-1. This serves as a migra-
tion signal to recruit monocytic cells into the liver, which
eventually mature into differentiated RHMs.
Our results are consistent with previous reports
(16,32,33), which show that monocyte-derived infil-
trating liver macrophages, which we term RHMs, are
smaller, contain fine granules in the cytoplasm, and are
F4/80dmCD11b+CCR2+ (16), CD11b+Ly6ChiLy6G2 (32),
or CD45+CD11c2F4/80lowCD11bhigh cells (33), whereas
KCs appear as larger cells with multiple phagocytic gran-
ules and are F4/80highCD11blow. A complicating factor in
comparing results from different published reports
relates to the technical difficulties in isolating and distin-
guishing KCs from RHMs. Different isolation methods,
including cell adherence, density-gradient centrifugation,
centrifugal elutriation, and cell sorting, have been used to
enrich or purify KCs and the RHM fraction (16,31–33).
Moreover, distinction of KCs from RHMs has been based
on the expression of F4/80, CD11b (16,32,33), and/or
CD68 (34). However, these markers are not expressed
exclusively on KCs or RHMs but are expressed by both
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and on other myeloid cells, such as dendritic cells and
polymononuclear cells (34).
To overcome these difficulties in clearly defining KCs
from RHMs, our methods use fluorescent markers to
differentially label RHMs and KCs. To identify RHMs, we
use a macrophage tracking technique in which donor blood
monocytes are labeled ex vivo with PKH26 and then injected
into recipient mice (17). We found the appearance of these
fluorescently labeled monocytes as monocytic cells and sub-
sequently as differentiated macrophages in the liver. KCs are
labeled by injecting FITC-dyed beads, which are taken up by
all phagocytic cell types in the liver (21). That the latex beads
might also be taken up by liver sinusoidal endothelial cells
(LSECs) is unlikely, because LSECs possess a maximum ca-
pacity of uptake for particles sized at ;0.1 mm and have
very low capacity for the uptake of particles ;0.5 mm in
diameter (35). In contrast, the capacity of KCs to ingest the
larger particles is not decreased, even when the particle di-
ameter increases much more (36,37), possibly up to the size
of cells. To be certain of this, we assessed LSEC markers
(Pecam-1, VAP-1, Stabillin-2, and CD209a) (38) in our
RNA-seq database from FITC-labeled KCs and PKH26+
RHMs. Overall, LSEC marker gene expression counts were
low and not different between FITC-labeled KCs versus
A B
C D
Figure 4—RNA-seq analysis of KCs and RHMs from NC- and HFD-fed mice. A: Principal component analysis of expressed genes in KCs
and RHMs from NC- or HFD-fed mice. Samples representing three biological replicates cluster together (KC-NC, red; KC-HFD, blue; RHM-
NC, green; RHM-HFD, black). B: Bar chart shows the number of differentially expressed genes between cell types (KC vs. RHM) and diets
(NC vs. HFD). C: Venn diagram shows common and distinct differentially expressed genes induced by the HFD within cell types. D: Heat
map shows differentially expressed inflammatory response genes between KCs and RHMs from mice fed NC and the HFD in a four-way
comparison. Gene counts were adjusted for cell number as KC increase 1.17-fold on HFD and RHMs increase 5.8-fold. Upregulated genes
are colored red, downregulated genes are colored blue, and darker colors reflect higher fold changes. RNA-seq studies used three
biological replicates per each group.
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PKH26+ RHMs (data not shown). Therefore, contamination
by LSEC in FITC-labeled KCs is negligible.
After lethal irradiation, the radioresistant KCs survive
and are marked by the FITC fluorescent beads. Using
these approaches, we were able to monitor the numbers
of RHMs and KCs in the lean and obese state and to
assess their function after cell sorting. Interestingly, KC
numbers were similar in the lean compared with the obese
state, whereas RHM content increased approximately
sixfold in obesity. In addition, a large set of inflammatory
pathway genes was induced in the RHMs from HFD mice,
whereas inflammatory pathway induction in KCs was only
modest. Given this approximately sixfold increase in
RHM numbers in HFD mice combined with the increased
RHM inflammatory gene induction per cell, we suggest
that RHMs are the major contributors to the hepatic
inflammatory state in obesity. In addition, we provide
evidence that factors secreted from HFD RHMs can
cause hepatic insulin resistance, because CM derived
from these cells directly stimulated HGO in hepatocytes
and blocked the normal effect of insulin to inhibit
hepatocyte HGO. In contrast, CM derived from KCs
did not exhibit this effect.
Steatosis is the characteristic hepatic manifestation
in insulin-resistant states (39,40). This steatotic state,
termed nonalcoholic fatty liver disease, can progress to
nonalcoholic steatohepatitis, which imparts a high risk for
development of fibrosis and cirrhosis (41,42). Immune
cell accumulation and activation in the livers from obese
rodents and humans are clearly the underlying cause of
obesity-induced hepatic inflammation but, most likely,
also play a role in the development of steatosis (43,44).
Thus, inflammatory cytokines, such as TNF-a, can stim-
ulate hepatocyte lipogenesis, ceramide production, and
adipocyte lipolysis, all of which can contribute to hepatic
steatosis (45–49). Furthermore, depletion of hepatic
phagocytic cells by clodronate administration has a marked
effect to ameliorate hepatic insulin resistance and steatosis
(50,51). Thus, RHMs and KCs are important contributors
to the underlying hepatic inflammatory state in obesity and
may also be pathophysiologically important in the develop-
ment of steatosis.
Table 1—Cell surface markers to distinguish between KCs and RHMs*
Symbol Description
NC HFD
KC RHM f(KC/RHM) KC RHM f(KC/RHM)
KC marker†
F8 Coagulation factor VIII 20,355 4,238 5 12,074 1,198 10
Kit Kit oncogene 11,300 2,186 5 5,430 492 11
Wnt2 Wingless-related MMTV integration site 2 4,836 818 6 2,580 233 11
Prelp Proline arginine-rich end leucine-rich repeat 3,485 699 5 2,383 234 10
Masp1 Mannan-binding lectin serine peptidase 1 2,396 450 5 1,915 182 11
Vwf Von Willebrand factor homolog 2,320 416 6 787 121 7
Wnt9b Wingless-type MMTV integration site 9B 1,149 156 7 288 21 14
Selp Selectin, platelet 973 178 5 1,006 87 12
Cdh13 Cadherin 13 929 114 8 982 64 15
Dkk3 Dickkopf homolog 3 (Xenopus laevis) 911 156 6 447 49 9
Tnxb Tenascin XB 828 154 5 577 41 14
Col3a1 Collagen, type III, a 1 752 100 8 711 46 15
Fbln2 Fibulin 2 355 61 6 397 32 12
Pdgfd Platelet-derived growth factor, D polypeptide 343 66 5 231 23 10
Col1a2 Collagen, type I, a 2 381 59 6 379 29 13
Col1a1 Collagen, type I, a 1 357 50 7 423 20 21
RHM marker†
C1qa Complement component 1, q subcomponent,
a polypeptide
15,635 80,760 5 39,139 107,329 3
C1qc Complement component 1, q subcomponent,
C chain
15,459 74,157 5 34,129 98,710 3
Apoc1 Apolipoprotein C-I 2,510 12,325 5 2,734 10,236 4
C4b Complement component 4B (Chido blood group) 2,361 7,773 3 2,798 8,656 3
Gbp2b Guanylate binding protein 2b 1,156 5,569 5 3,824 13,625 4
C6 Complement component 6 927 8,118 9 1,142 6,303 6
Kif23 Kinesin family member 23 912 2,633 3 1,257 3,436 3
Cpq Carboxypeptidase Q 661 2,884 4 1,571 4,243 3
C4a Complement component 4A (Rodgers blood group) 221 869 4 224 780 3
Kcp Kielin/chordin-like protein 75 471 6 63 231 4
Slc1a3 Solute carrier family 1 (glial high affinity glutamate
transporter), member 3
36 220 6 72 228 3
*Differentially expressed genes between KC and RHMs that were classified within the GO cellular component term “extracellular region
part” are listed. †The top 16 KC marker genes listed are expressed at least fivefold higher in KC vs. RHM from NC- or HFD-fed mice. The
top 11 RHM markers are all expressed at least threefold higher in RHMs vs. KCs. All markers are expressed at 200 counts per gene or
more. RNA-seq studies used three biological replicates per each group.
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KCs are the largest population of resident macrophages
in the liver. They resemble other resident tissue macro-
phages in nonlymphoid organs; however, their location
within hepatic sinusoids enables intimate contact with
the circulation, facilitating their activity to clear bacterial
products and interact with blood-derived molecules
(52,53). Because the morphology (Fig. 1) and gene expres-
sion patterns (Table 1) of KCs and RHMs are strikingly
different, this raises the question about the origin of
these two distinct cell types. Obviously, RHMs are derived
from circulating monocytes, which, in turn, are derived
from bone marrow progenitor cells. The origin of KCs,
and how KC populations are maintained over time, is
more controversial. One view is that KCs have a slow
rate of turnover, are not self-renewing, and are replen-
ished from bone marrow–derived monocytes (54,55). This
view is supported by bone marrow radiation chimera
experiments and chemical depletion studies, which find
that circulating monocytes can replenish depleted KC
populations (50,54,56). However, other transplantation
studies have not found evidence for bone marrow repop-
ulation of hepatic KCs, suggesting these cells are derived
from another source (29,57). This would be consistent
with reports for other tissue-resident macrophages, such
as microglia, showing an origin from non–bone marrow–
derived cells (58,59). With this formulation, KCs might
arise during early development from a liver progenitor cell
type. In this event, KCs would have self-renewing proper-
ties, and their population would not be sustained from
circulating monocytes. Because our studies showed that
the number of KCs was unchanged during HFD, whereas
the number of RHMs was increased several fold, and be-
cause the gene expression patterns under both NC and
HFD conditions are so different between KCs and RHMs,
our studies would certainly be consistent with the concept
of an intrahepatic, non–bone marrow–derived origin of
KCs with an extrahepatic, bone marrow origin for RHMs.
Obesity is associated with a large increase in RHMs,
which are a major cause of the inflammatory state in the
livers of HFD/obese mice, whereas KCs provide a trigger
for this massive RHM infiltration. Factor(s) secreted from
HFD mouse RHMs appear to contribute to hepatic insulin
resistance, whereas KC-derived factors do not. Moreover,
we provide the transcriptome analysis of KCs and RHMs.
This analysis shows that KCs widely differ in their
transcriptome compared with RHMs (Fig. 4). We also
identified and verified the cell surface markers that dis-
tinguish KCs from RHMs (Table 1). This latter finding
could provide the opportunity for a direct isolation strat-
egy for KCs using specific surface markers.
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